Basic information Safety Supplier Related

Cyclohexanecarboxaldehyde, 4,4-difluoro- (9CI)

Basic information Safety Supplier Related

Cyclohexanecarboxaldehyde, 4,4-difluoro- (9CI) Basic information

Product Name:
Cyclohexanecarboxaldehyde, 4,4-difluoro- (9CI)
Synonyms:
  • Cyclohexanecarboxaldehyde, 4,4-difluoro- (9CI)
  • 4,4-Difluoro Cyclohexanecarboxaldehyde
  • 4,4-difluorocyclohexane-1-carbaldehyde
  • Cyclohexanecarboxaldehyde, 4,4-difluoro-
  • 4,4-Difluoro-cyclohexanecarbaldehyde
  • Cyclohexanecarboxaldehyde, 4,4-difluor
  • 4,4-DIFLU0R0 CYCLOHEXANECARBOXALDEHYDE
  • 4,4-difluorocyclohexane-1-carbaldehyde 95%
CAS:
265108-36-9
MF:
C7H10F2O
MW:
148.15
Product Categories:
  • HALIDE
  • ALDEHYDE
Mol File:
265108-36-9.mol
More
Less

Cyclohexanecarboxaldehyde, 4,4-difluoro- (9CI) Chemical Properties

Boiling point:
165.0±40.0 °C(Predicted)
Density 
1.10±0.1 g/cm3(Predicted)
storage temp. 
Inert atmosphere,Store in freezer, under -20°C
form 
solid
Appearance
Colorless to light yellow Liquid
InChI
InChI=1S/C7H10F2O/c8-7(9)3-1-6(5-10)2-4-7/h5-6H,1-4H2
InChIKey
DNSDOTKSZMHDOR-UHFFFAOYSA-N
SMILES
C1(C=O)CCC(F)(F)CC1
More
Less

Safety Information

Hazard Codes 
Xi
HazardClass 
IRRITANT
HS Code 
2913000090
More
Less

Cyclohexanecarboxaldehyde, 4,4-difluoro- (9CI) Usage And Synthesis

Uses

4,4-Difluorocyclohexanecarbaldehyde is used in the preparation of heteroaryl acid derivative and methods for treating oxalate-related diseases.

Synthesis

178312-48-6

265108-36-9

Oxalyl chloride (0.35 mL, 4.16 mmol) was dissolved in anhydrous dichloromethane (15.0 mL) under nitrogen protection and cooled to -78 °C. Subsequently, dimethyl sulfoxide (0.27 mL, 3.84 mmol) was slowly added dropwise and stirred at -78 °C for 15 min. Next, a solution of (4,4-difluorocyclohexyl)methanol (0.48 g, 3.20 mmol) in anhydrous dichloromethane (10 mL) was added dropwise. The reaction mixture was continued to be stirred at -78 °C for 1 hour. After that, triethylamine (1.27 mL, 9.60 mmol) was added slowly and dropwise. The reaction mixture was gradually warmed to room temperature and subsequently concentrated to dryness under reduced pressure. The crude product was dissolved in ether (30 mL) and washed sequentially with saturated aqueous sodium bicarbonate solution and ammonium chloride solution (30 mL each). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give 4,4-difluorocyclohexanecarboxaldehyde (0.39 g, 82% yield), which could be used in subsequent reactions without further purification.1H NMR (DMSO-d6) δ: 9.61 (s, 1H), 2.05-1.73 (m, 7H), 1.64-1.51 (m, 2H).

References

[1] Patent: WO2014/144836, 2014, A2. Location in patent: Paragraph 0095; 0996
[2] European Journal of Medicinal Chemistry, 2016, vol. 111, p. 138 - 159
[3] Patent: WO2014/184561, 2014, A1. Location in patent: Page/Page column 72
[4] Journal of Medicinal Chemistry, 2017, vol. 60, # 7, p. 2780 - 2789
[5] Patent: WO2009/65035, 2009, A1. Location in patent: Page/Page column 81-82

Cyclohexanecarboxaldehyde, 4,4-difluoro- (9CI)Supplier

Cochemical Ltd. Gold
Tel
029-86115547 17791676824
Email
sales@cochemical.com
Energy Chemical Gold
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Aikon International Limited Gold
Tel
025-58851090 15955137747
Email
sales01@aikonchem.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18
JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Email
sales@jingyan-chemical.com